Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional...

Background: Natalizumab, a highly specific alpha4-integrin antagonist, , has recently been http://t.co/yJQztim7Cg

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/yJQztim7Cg